Literature DB >> 11110741

Prevention of ischaemic stroke.

G Gubitz1, P Sandercock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11110741      PMCID: PMC1119171          DOI: 10.1136/bmj.321.7274.1455

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

Authors:  P R Hebert; J M Gaziano; K S Chan; C H Hennekens
Journal:  JAMA       Date:  1997 Jul 23-30       Impact factor: 56.272

2.  Mortality by cause for eight regions of the world: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-03       Impact factor: 79.321

3.  Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Stroke Unit Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1997-04-19

4.  Smoking and death: the past 40 years and the next 40.

Authors:  R Peto
Journal:  BMJ       Date:  1994-10-08

5.  Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators.

Authors:  C Morocutti; G Amabile; F Fattapposta; A Nicolosi; S Matteoli; M Trappolini; G Cataldo; G Milanesi; M Lavezzari; F Pamparana; S Coccheri
Journal:  Stroke       Date:  1997-05       Impact factor: 7.914

6.  A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.

Authors: 
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

7.  Effect of antihypertensive treatment in patients having already suffered from stroke. Gathering the evidence. The INDANA (INdividual Data ANalysis of Antihypertensive intervention trials) Project Collaborators.

Authors:  F Gueyffier; J P Boissel; F Boutitie; S Pocock; J Coope; J Cutler; T Ekbom; R Fagard; L Friedman; K Kerlikowske; M Perry; R Prineas; E Schron
Journal:  Stroke       Date:  1997-12       Impact factor: 7.914

8.  European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

Authors:  H C Diener; L Cunha; C Forbes; J Sivenius; P Smets; A Lowenthal
Journal:  J Neurol Sci       Date:  1996-11       Impact factor: 3.181

9.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

Review 10.  Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS.

Authors: 
Journal:  J Hypertens Suppl       Date:  1996-09
View more
  5 in total

1.  Use of antithrombotic medications among elderly ischemic stroke patients.

Authors:  Judith H Lichtman; Lisa Naert; Norrina B Allen; Emi Watanabe; Sara B Jones; Lisa C Barry; Dawn M Bravata; Larry B Goldstein
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-11-23

2.  Long term risks of stroke, myocardial infarction, and vascular death in "low risk" patients with a non-recent transient ischaemic attack.

Authors:  T G Clark; M F G Murphy; P M Rothwell
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-05       Impact factor: 10.154

3.  Suicide in a patient with symptomatic carotid occlusion.

Authors:  J K Lovett; P M Rothwell
Journal:  J R Soc Med       Date:  2002-02       Impact factor: 18.000

4.  Arterial indications for the low molecular weight heparins.

Authors:  Walter Ageno; Menno V Huisman
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001

5.  Population based study of early risk of stroke after transient ischaemic attack or minor stroke: implications for public education and organisation of services.

Authors:  A J Coull; J K Lovett; P M Rothwell
Journal:  BMJ       Date:  2004-01-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.